Delivery Order SPE2DB20D7059-SPE2DB25FQHF0

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.06 delivery order is for the supply of Fluticasone-Salmeterol 45-21 12GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,213.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat respiratory conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,261.11 firm fixed-price delivery order is for the supply of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication, with an ultimate completion date of December 3, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,977.80 delivery order contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.63 firm fixed-price delivery order is for the supply of Fluticasone-Salmeterol 115-21 12GM, a prescription medication. The contract has an ultimate completion date of April 10, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,841.64 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,902.28 firm fixed-price delivery order is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used for respiratory conditions. The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,326.87 firm-fixed-price delivery order is for the supply of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication, with a period of performance through February 2025. The award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,258.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a period of performance through May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQHF0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,762.46 firm-fixed-price delivery order is for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used in the treatment of respiratory conditions.

The contract has a period of performance through May 29, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is part of the company's broader efforts to provide a wide range of pharmaceutical products and medical supplies to federal agencies, particularly the Defense Health Agency and U.S. Coast Guard.

Generated 8/27/25, 9:43 AM